Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Risperdal Jury “Blown Away” By Testimony On Study Manipulation; J&J Settles Texas Suit

This article was originally published in The Pink Sheet Daily

Executive Summary

In the midst of a trial, Johnson & Johnson agrees to pay $158 million to settle a suit by the state of Texas alleging the company promoted Risperdal off-label to children. Two states previously won jury verdicts over the company’s marketing of the antipsychotic.

You may also be interested in...

J&J Challenges Risperdal Penalty As First Amendment Violation

In case that could impact use of state unfair trade practices statutes, Janssen seeks Supreme Court review of South Carolina’s $124 million judgment for Risperdal labeling and Dear Doctor letter.

FDA Warning Letter Is Inadmissible Hearsay, Arkansas Supreme Court Says In Tossing J&J Judgment

Court throws out $1.2 billion award to the state of Arkansas over Risperdal promotions.

Pharma v. State AGs: GlaxoSmithKline Is Fifth Firm To Challenge Hiring Of Private Counsel

GSK filed suit against the attorney general of Louisiana seeking a court order prohibiting the state from using private counsel in litigation over Avandia marketing; the state is seeking more than $10 billion in penalties.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts